Literature DB >> 6470528

Production of menaquinones by intestinal anaerobes.

K Ramotar, J M Conly, H Chubb, T J Louie.   

Abstract

Ninety intestinal organisms (71 isolates from fecal samples of neutropenic patients with cancer or from various sites in patients with intraabdominal infections and 19 control strains) were examined by reverse-phase thin-layer chromatography for their ability to produce menaquinones in vitro. Menaquinones were found in all of 24 organisms of the Bacteroides fragilis group. Two other Bacteroides species, Bacteroides disiens and Bacteroides bivius, also produced menaquinones. A single isolate of Bacteroides species lacked menaquinones. These constituents were found in all of five strains of Escherichia coli, all of four strains of Klebsiella pneumoniae, five of eight strains of Propionibacterium species, two of five strains of Eubacterium species, and the one strain each of Arachnia propionica and Veillonella parvula tested. No menaquinones were detected in organisms of the genera Fusobacterium, Clostridium, Bifidobacterium, Lactobacillus, Actinomyces, Peptococcus, or Peptostreptococcus. These findings suggest that E. coli, Bacteroides species, and some gram-positive, anaerobic, non-spore-forming bacilli produce menaquinones that may be a source of vitamin K in patients who are deprived of exogenous vitamin K1.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470528     DOI: 10.1093/infdis/150.2.213

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

Review 1.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

2.  Microbiota conservation and BMI signatures in adult monozygotic twins.

Authors:  Sebastian Tims; Catherine Derom; Daisy M Jonkers; Robert Vlietinck; Wim H Saris; Michiel Kleerebezem; Willem M de Vos; Erwin G Zoetendal
Journal:  ISME J       Date:  2012-11-29       Impact factor: 10.302

Review 3.  Gut and root microbiota commonalities.

Authors:  Shamayim T Ramírez-Puebla; Luis E Servín-Garcidueñas; Berenice Jiménez-Marín; Luis M Bolaños; Mónica Rosenblueth; Julio Martínez; Marco Antonio Rogel; Ernesto Ormeño-Orrillo; Esperanza Martínez-Romero
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

4.  Dependence of the product chain-length on detergents for long-chain E-polyprenyl diphosphate synthases.

Authors:  Jian-Jung Pan; Gurusankar Ramamoorthy; C Dale Poulter
Journal:  Biochemistry       Date:  2013-07-11       Impact factor: 3.162

5.  Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats.

Authors:  Ala Al Rajabi; Sarah L Booth; James W Peterson; Sang Woon Choi; John W Suttie; M Kyla Shea; Benchun Miao; Michael A Grusak; Xueyan Fu
Journal:  J Nutr       Date:  2012-03-21       Impact factor: 4.798

6.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

7.  Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.

Authors:  M Joshi; W C Anthony; J H Tenney; G L Drusano; E S Caplan; H C Standiford; A Henson; J W Warren
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

8.  Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.

Authors:  R L Nichols; M A Wikler; J T McDevitt; A L Lentnek; J A Hosutt
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Vitamin K1 and K2 status and faecal flora in breast fed and formula fed 1-month-old infants.

Authors:  K Fujita; F Kakuya; S Ito
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

Review 10.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.